Inflammation in the molecular pathogenesis of cancer and atherosclerosis

Reumatologia Clinica

Volumn 5, Issue SUPPL. 1, 2009, Pages 40-43

  Vidal Vanaclocha, Fernando ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Angiogenesis; Atherosclerosis; Cancer; Cytokines; Inflammation; Metastasis; Oxidative stress

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CHEMOKINE; CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR Y; CELL ADHESION MOLECULE; I KAPPA B; PROTEINASE;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; CELL CYCLE PROGRESSION; CELL INFILTRATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; CLINICAL FEATURE; DISEASE COURSE; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; HEMOSTASIS; HEREDITY; HUMAN; IMMUNOCOMPETENT CELL; METASTASIS; NEOPLASM; OXIDATIVE STRESS; PATHOGENESIS; CANCER GROWTH; CELL CYCLE REGULATION; DOWN REGULATION; EXTRACELLULAR MATRIX; MOLECULAR PATHOLOGY; MOLECULARLY TARGETED THERAPY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STENOSIS; STROMA CELL;

EID: 64849109740     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2008.12.008     Document Type: Article

References (17)

1. Lijnen H.R. Elements of the fibrinolytic system. Ann N Y Acad Sci 936 (2001) 226-236
2. Engelse M.A., Hanemaaijer R., Koolwijk P., and Van Hinsbergh V.W. The fibrinolytic system and matrix metalloproteinases in angiogenesis and tumor progression. Semin Thromb Hemost 30 (2004) 71-82
3. Kuper H., Adami H.O., and Trichopoulos D. Infections as a major presentable cause of human cancer. J Intern Med 248 (2000) 171-183
4. Pisani P., Parkin D.M., Munoz N., and Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6 (1997) 387-400
5. Klein E.A., and Silverman R. Inflammation, infection, and prostate cancer. Curr Opin Urol 18 (2008) 315-319
6. Elsharkawy A.M., and Mann D.A. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46 (2007) 590-597
7. Mazzucchelli L., Blaser A., and Kappeler A. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 104 (1999) R49-R54
8. Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99 (2008) 1501-1506
9. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
10. Maeda S., and Omata M. Inflammation and cancer: role of nuclear factor-kappa B activation. Cancer Sci 99 (2008) 836-842
11. Vidal-Vanaclocha F., Mendoza L., Telleria N., Salado C., Valcárcel M., Gallot N., et al. Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev 25 (2006) 417-434
12. Vidal-Vanaclocha F. The Prometastatic Microenvironment of the Liver. Cancer Microenvironment 1 (2008) 113-129
13. Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 (2004) III-27-III-32
14. Li J.J., and Gao R.L. Should atherosclerosis be considered a cancer of the vascular wall?. Med Hypotheses 64 (2005) 694-698
15. Stoll G., and Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37 (2006) 1923-1932
16. Ross J.S., Stagliano N.E., Donovan M.J., Breitbart R.E., and Ginsburg G.S. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci 947 (2001) 271-292
17. Morganti M., Carpi A., Nicolini A., Gorini I., Glaviano B., Fini M., et al. Atherosclerosis and cancer: common pathways on the vascular endothelium. Biomed Pharmacother 56 (2002) 317-324